28 SKIN CARE
Figure 1: Graphical illustration portrays the biological processes taking place in the skin in response to exposome exposure. Exposure of UV, pollution and other external triggers results in ROS formation, cytokine-driven inflammation and lipid mediator signaling. Subsequently, increased PGE2 level compromise filaggrin expression and disrupt tight junctions resulting in impaired lipid lamellae and barrier. A compromised barrier and age-related decline with SASP results in low-grade inflammation that provokes in turn further matrix and barrier damage via MMPs
the use of petrochemical sources is not the best choice long term solution from a sustainable point of view. Alternative botanical sources, such as
chamomile, also pose challenges when high- purity material is required at scale. Chamomile essential oil is chemically complex, often contains significant amounts of bisabolol oxides rather than free alpha-bisabolol, and may require additional purification to obtain a consistent, high-quality ingredient stream. This has helped drive interest in biotechnological production routes capable of delivering consistent purity and predictable composition.2 For cosmetic formulators, this matters
because sourcing affects more than sustainability narratives. It affects reproducibility, impurity profiles, and ultimately the reliability of biological performance from batch to batch. In a category such as sensitive skin, where tolerance and consistency are central to product success, a biotech route provides a scientifically and commercially relevant foundation. To address these limitations, a custom-
engineered yeast was developed to produce pure (-)-α-bisabolol using precision fermentation with renewable feedstocks, such as corn-derived glucose. Unlike chemical synthesis, which yields a mixture of four bisabolol isomers ((-)-α-bisabolol, (+)-α-bisabolol, (-)-epi-α-bisabolol, and (+)-epi- α-bisabolol)—this biotechnological approach delivers only the desired (-)-α-bisabolol, molecularly identical to that previously extracted from candeia wood. By shifting from fossil-based to renewable
PERSONAL CARE MAGAZINE May 2026
inputs, the natural origin index (NOI) rises from 0 for chemically synthesized bisabolol to 1 for the biotechnologically produced version. Moreover, replacing the conventional chemical catalyst with a biodegradable biocatalyst (yeast) derived from natural sources further enhances the sustainability and environmental responsibility of the process. Just as importantly, the pairing strategy is purposeful rather than decorative. Bisabolol contributes a well-established calming backbone, while ginger broadens the activity profile toward lipid-mediator control and antioxidative support. This gives the combination a more useful scientific identity than either component would achieve alone: one anchors tolerability and familiarity; the other expands relevance to modern stress biology, especially in skin exposed to repeated environmental assaults.
From single-pathway calming to multi-pathway support A more complete sensitive skin strategy must reflect the biology of chronic, low-grade irritation. Ageing research has helped sharpen this understanding through the concept of inflammaging, defined as a persistent, sterile, low- level inflammatory state that increases with age and remains distinct from immunosenescence.3,4 In skin, inflammaging is associated with
elevated mediators such as IL-6, IL-8, TNF-α, and IL-1 family of cytokines, as well as progressive disruption of barrier and repair processes.3,4,10 These changes are highly relevant to
sensitive skin, even beyond older consumers. Environmental stress, repeated micro-irritation,
impaired barrier repair, and oxidative insults can all create a local tissue state that resembles a low- grade inflammatory drift. The practical consequence is that skin becomes easier to irritate and slower to normalize. For formulators, that means a soothing ingredient should ideally work upstream on inflammatory mediators while also addressing barrier competence and exposome resilience. Within this framework, the bisabolol–ginger
complex is best understood not as a simple anti- redness additive, but as a coordinated system. Our testing indicates activity at multiple levels, from cytokine modulation in keratinocytes to support of barrier-associated structural pathways and protection against oxidative stressors encountered in daily life (Figures 2, 3 and 5). This breadth is what gives the material a stronger formulation story than a conventional one-dimensional soothing claim.
Mechanistic evidence: cytokines and lipid mediators The first layer of evidence concerns inflammatory signaling in keratinocytes. Under induced inflammatory conditions, our in vitro data show that the blend reduced several key cytokines associated with irritation biology: IL-6 by 48%, IL-8 by 33%, IL-1α by 75–77%, and TNF-α by up to 64% (Figure 2). These mediators are not merely analytical biomarkers. They participate directly in the signaling networks linked to redness, burning sensations, immune activation, and delayed recovery after insult.3,4,10 This cytokine profile is important because it suggests upstream modulation rather than purely
www.personalcaremagazine.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
